Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of Schizophrenia
Clinical trial NCT03397134 · COMPLETED
Trial details
- NCT number
- NCT03397134
- Sponsor
- Minerva Neurosciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-15
- Primary completion
- 2020-05-26
- Enrollment
- 515
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.